ADVANCED ENZYME TECHNOLOGIES
|
The Current P/S Ratio of ADVANCED ENZYME TECHNOLOGIES is 7.06.
Share Price | ₹393.9 | May 10,2024 |
Market Cap | ₹4,403.2 Cr | |
Sales-TTM | ₹623.9 Cr | TTM-Consolidated Results |
Price/Sales | 7.06x | Calculated as Market Cap/Sales |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PS (Price/Sales) ratio of ADVANCED ENZYME TECHNOLOGIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹4,403.2 Cr] as on May 10,2024
(/) Sales [ ₹623.9 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 7.06x ]
Thus, for ADVANCED ENZYME TECHNOLOGIES , the investors are currently willing to pay '7.06 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ADVANCED ENZYME TECHNOLOGIES !
The chart below summarizes the trend in P/S Ratio of ADVANCED ENZYME TECHNOLOGIES over the last five years.
Historical PS (Price/Sales) ratio chart of ADVANCED ENZYME TECHNOLOGIES
PS Ratio Performance Analysis for ADVANCED ENZYME TECHNOLOGIES
- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio for fiscal years ending Mar2023 to Mar2019 averaged 5.38x.
- ADVANCED ENZYME TECHNOLOGIES 's operated at median p/e ratio of 4.87x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ADVANCED ENZYME TECHNOLOGIES 's p/e ratio peaked in Mar2021 at 7.68x.
- ADVANCED ENZYME TECHNOLOGIES 's p/e ratio hit its five-year low in Mar2020 of 3.6x.
How does ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
---|---|---|---|
ADVANCED ENZYME TECHNOLOGIES | 623.9 | 7.06 | 4,403.2 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 47,444.6 | 7.62 | 361,400.0 |
CIPLA LTD | 25,774.1 | 4.20 | 108,147.0 |
DR REDDYS LABORATORIES LTD | 28,011.1 | 3.52 | 98,703.0 |
ZYDUS LIFESCIENCES LTD | 19,024.2 | 5.20 | 98,917.8 |
DIVIS LABORATORIES LTD | 7,492.8 | 13.43 | 100,664.0 |
MANKIND PHARMA LTD | 9,946.3 | 9.01 | 89,657.7 |
TORRENT PHARMACEUTICALS LTD | 10,474.0 | 8.41 | 88,044.9 |
LUPIN LTD | 20,010.8 | 3.67 | 73,368.9 |
AUROBINDO PHARMA LTD | 27,894.7 | 2.37 | 66,132.0 |
ABBOTT INDIA LTD | 5,848.9 | 9.58 | 56,034.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ADVANCED ENZYME TECHNOLOGIES 's P/S Ratio
Top 10 Industry Peers | PS Ratio |
---|---|
Min industry PS | 2.37x |
Max industry PS | 13.43x |
Median industry PS | 7.06x |
Average industry PS | 6.73x |
You may also like the below Video Courses